Hepatology is the branch of medicine focused on the liver, gallbladder, bile ducts, and pancreas. These organs are collectively known as the biliary tract, connected by a network of ducts that produce and transport bile. A hepatologist is the specialist who diagnoses and treats diseases affecting any part of this system, from viral infections and fatty liver disease to liver cancer and conditions severe enough to require a transplant.
What a Hepatologist Actually Treats
The liver is the central organ in hepatology, but the specialty extends to every structure the liver works with. Because bile flows from the liver through a series of ducts into the gallbladder and interacts with the pancreas during digestion, a hepatologist needs expertise across all of these organs. That means conditions like bile duct blockages, gallbladder inflammation, and certain pancreatic problems also fall under their care.
The range of liver diseases alone is broad. Some of the most common include:
- Viral hepatitis (hepatitis A, B, C, D, and E), infections that inflame the liver and can become chronic
- Fatty liver disease, now the most common chronic liver condition worldwide, affecting roughly 38% of adults globally
- Cirrhosis, severe scarring of the liver from long-term damage of any cause
- Autoimmune hepatitis, where the immune system attacks liver cells
- Genetic conditions like hemochromatosis (iron overload), Wilson disease (copper buildup), and porphyria
- Bile duct diseases such as primary biliary cholangitis and primary sclerosing cholangitis
- Liver cancer, often arising in a liver already damaged by cirrhosis or chronic hepatitis
How Hepatology Differs From Gastroenterology
Gastroenterology covers the entire digestive system, from the esophagus to the rectum, including the liver. Hepatology is a narrower focus within that field. Most hepatologists trained first as gastroenterologists and then pursued additional specialization. In practice, a general gastroenterologist handles many routine liver issues, like an initial workup for abnormal liver enzymes. A hepatologist typically steps in when the liver problem is complex, advanced, or potentially heading toward transplant.
The clearest dividing line is transplant hepatology. This is a formally recognized subspecialty with its own board certification, and these specialists manage patients before, during, and after liver transplantation. General gastroenterologists do not perform this role.
When Patients Get Referred
Most people see a hepatologist after a primary care doctor or gastroenterologist identifies a liver problem that needs deeper investigation. One common trigger is persistently elevated liver enzymes on blood tests. If those levels remain abnormal for six months or more despite lifestyle changes and initial treatment, guidelines recommend referral to a specialist for further evaluation. Other reasons include unexplained jaundice, signs of advanced scarring, a new diagnosis of chronic hepatitis B or C, or imaging that reveals a liver mass.
Physical signs that often prompt a closer look include yellowing of the skin or eyes, persistent fatigue paired with upper-right abdominal discomfort, unexplained fluid buildup in the abdomen, and easy bruising or bleeding. None of these are exclusive to liver disease, but together they raise enough suspicion to warrant specialized assessment.
Key Diagnostic Tools
Liver biopsy has long been considered the gold standard for evaluating how much scarring exists in the liver. A small needle removes a tiny tissue sample, which a pathologist examines under a microscope. The drawback is that it’s invasive, requires a half-day hospital visit, carries a small risk of pain and bleeding, and samples such a small piece of the liver that staging errors occur in up to 25 to 30% of cases. Two pathologists can even interpret the same sample differently.
Because of these limitations, noninvasive alternatives have become increasingly important. The most widely used is transient elastography (often known by the brand name FibroScan). This device sends a sound wave through the liver and measures how fast it travels. Stiffer liver tissue, meaning more scarring, transmits the wave faster. The result is expressed as a stiffness score. The test takes only five to seven minutes, requires no sedation, causes no pain, and can be done right in the clinic. It has largely replaced biopsy as the first-line tool for assessing fibrosis in many settings.
Blood-based scoring systems that combine routine lab values into a fibrosis estimate are also common. Hepatologists use these alongside imaging to build a complete picture before deciding whether a biopsy is truly necessary.
Liver Transplant Evaluation
For patients with end-stage liver disease, transplant evaluation is one of the most consequential things a hepatologist does. Transplantation is generally considered when a patient’s expected survival without a new liver is less than one year and their quality of life has significantly deteriorated. The most common reasons include decompensated cirrhosis (where the liver can no longer perform its basic functions), acute liver failure, and liver cancer within specific size criteria.
Not everyone qualifies. Active uncontrolled infections, failure of four or more organ systems, irreversible brain damage from liver-related toxin buildup, and ongoing substance use disorders can all disqualify a patient. The evaluation process is thorough, assessing whether each organ system can tolerate major surgery and recover afterward. Scoring systems that factor in kidney function, blood clotting ability, and sodium levels help determine how urgently a patient needs a transplant and where they fall on the waiting list.
Why Hepatology Is Growing
The field has expanded significantly in recent decades, driven largely by the global rise of fatty liver disease. Now formally called metabolic dysfunction-associated steatotic liver disease (MASLD), it affects roughly 38% of adults worldwide and is overtaking viral hepatitis as the leading cause of cirrhosis and liver-related death. In some countries, the prevalence is even higher: a 2022 nationwide study in China found liver fat in over 44% of the population.
This shift has changed the profile of a typical hepatology patient. Where the specialty once centered heavily on hepatitis B and C, it now increasingly manages the liver consequences of obesity, diabetes, and metabolic syndrome. The first medication specifically approved for the scarring caused by fatty liver disease, resmetirom, reached the market recently. It works by activating a thyroid hormone receptor in liver cells to reduce fat accumulation and inflammation. Other drug classes, including the same type of medications used for diabetes and weight loss (GLP-1 receptor agonists), are in clinical trials for this condition.
Training Path for Hepatologists
Becoming a hepatologist requires one of the longest training pipelines in medicine. After medical school, a physician completes a three-year internal medicine residency, then a three-year gastroenterology fellowship. Those who want formal transplant hepatology certification add a fourth fellowship year focused specifically on managing transplant patients. An alternative track allows trainees to complete both gastroenterology and transplant hepatology within the same three-year fellowship. After training, they sit for a board certification exam jointly administered by the internal medicine and pediatrics boards.
Pediatric hepatologists follow a parallel path through pediatric residency and fellowship, treating infants, children, and teens with liver and biliary diseases. Conditions like biliary atresia, a blockage of bile ducts present at birth, are managed almost exclusively by pediatric hepatology teams.